Condensed Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 7,007,260	$ 12,077,640
Prepaid expenses and other current assets	624,520	807,356
Total current assets	7,631,780	12,884,996
Property and equipment, net	176,265	193,974
Other assets:
Goodwill	7,647,267	7,647,267
In-process research and development	118,600	118,600
Other non-current assets	566,466	620,674
Total assets	16,140,378	21,465,511
Current liabilities:
Accounts payable	344,800	561,090
Accrued expenses	1,171,164	1,944,431
Other current liabilities	264,472	263,392
Total current liabilities	1,780,436	2,768,913
Other non-current liabilities	270,994	326,282
Total liabilities	2,051,430	3,095,195
Commitments and Contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 10,101,034 and 10,095,176 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	1,011	1,010
Additional paid-in capital	95,287,156	94,619,818
Accumulated deficit	(81,199,219)	(76,250,512)
Total stockholders’ equity	14,088,948	18,370,316
Total liabilities and stockholders’ equity	$ 16,140,378	$ 21,465,511